1. Home
  2. TUSK vs RAPT Comparison

TUSK vs RAPT Comparison

Compare TUSK & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUSK
  • RAPT
  • Stock Information
  • Founded
  • TUSK 2014
  • RAPT 2015
  • Country
  • TUSK United States
  • RAPT United States
  • Employees
  • TUSK N/A
  • RAPT N/A
  • Industry
  • TUSK Oilfield Services/Equipment
  • RAPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUSK Energy
  • RAPT Health Care
  • Exchange
  • TUSK Nasdaq
  • RAPT Nasdaq
  • Market Cap
  • TUSK 131.4M
  • RAPT 194.2M
  • IPO Year
  • TUSK 2016
  • RAPT 2019
  • Fundamental
  • Price
  • TUSK $2.24
  • RAPT $11.74
  • Analyst Decision
  • TUSK
  • RAPT Buy
  • Analyst Count
  • TUSK 0
  • RAPT 5
  • Target Price
  • TUSK N/A
  • RAPT $33.60
  • AVG Volume (30 Days)
  • TUSK 98.4K
  • RAPT 105.9K
  • Earning Date
  • TUSK 08-08-2025
  • RAPT 08-07-2025
  • Dividend Yield
  • TUSK N/A
  • RAPT N/A
  • EPS Growth
  • TUSK N/A
  • RAPT N/A
  • EPS
  • TUSK N/A
  • RAPT N/A
  • Revenue
  • TUSK $188,567,000.00
  • RAPT N/A
  • Revenue This Year
  • TUSK N/A
  • RAPT N/A
  • Revenue Next Year
  • TUSK $28.22
  • RAPT N/A
  • P/E Ratio
  • TUSK N/A
  • RAPT N/A
  • Revenue Growth
  • TUSK 26.46
  • RAPT N/A
  • 52 Week Low
  • TUSK $1.68
  • RAPT $5.67
  • 52 Week High
  • TUSK $4.90
  • RAPT $26.56
  • Technical
  • Relative Strength Index (RSI)
  • TUSK 35.11
  • RAPT 58.44
  • Support Level
  • TUSK $2.11
  • RAPT $10.20
  • Resistance Level
  • TUSK $2.45
  • RAPT $13.50
  • Average True Range (ATR)
  • TUSK 0.12
  • RAPT 1.01
  • MACD
  • TUSK -0.03
  • RAPT -0.05
  • Stochastic Oscillator
  • TUSK 20.63
  • RAPT 77.46

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Share on Social Networks: